Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIa study

References

• World Health Organisation Diabetes Programme Geneva, Switzerland World Health Organisation 2012 Available from: http://www.who.int/diabetes/en/ Accessed June 26, 2014
   Google Scholar
• Jang JE Kim YT Park BK Cheong IY Kim DH Subclinical ulnar neuropathy at the elbow in diabetic patients Ann Rehabil Med 2014 38 64 71 24639928
   PubMedGoogle Scholar
• Ko SH Cha BY Diabetic peripheral neuropathy in type 2 diabetes mellitus in Korea Diabetes Metab J 2012 36 6 12 22363916
   PubMedGoogle Scholar
• Zorrilla E Frati A Lozano O Villalpando S Boulton AJM Neuropatía diabética. Conceptos actuales sobre etiopatogénesis, diagnóstico y tratamiento [Diabetic neuropathy. Current concepts on etiopathogenesis, diagnosis, and treatment] Gac Med Mex 1994 130 18 25 Spanish 7557046
   PubMedGoogle Scholar
• Dyck PJ Detection, characterization and staging of polyneuropathy: assessed in diabetics Muscle Nerve 1988 11 21 32 3277049
   PubMed Web of Science ®Google Scholar
• Bril V Werb MR Greene DA Sima AA Single-fiber electromyography in diabetic peripheral polyneuropathy Muscle Nerve 1996 19 2 9 8538665
   PubMed Web of Science ®Google Scholar
• Dumitru D Electrodiagnostic Medicine 2nd ed Philidelphia, PA, USA Hanley and Belfus 2000
   Google Scholar
• Duckworth W Hyperglycemia and cardiovascular disease Curr Atheroscler Rep 2001 3 383 391 11487449
   PubMedGoogle Scholar
• Bashan N Kovsan J Kachko I Ovadia H Rudich A Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species Physiol Rev 2009 89 27 71 19126754
   PubMed Web of Science ®Google Scholar
• Sima AA Structure-function interactions in the therapeutic response of diabetic neuropathy J Diabetes Complications 1992 6 64 68 1562761
   PubMedGoogle Scholar
• Dyck PJ Giannini C Pathologic alterations in the diabetic neuropathies of humans: a review J Neuropathol Exp Neurol 1996 55 1181 1193 8957441
   PubMed Web of Science ®Google Scholar
• Brownlee M Biochemistry and molecular cell biology of diabetic complications Nature 2001 414 813 820 11742414
   PubMed Web of Science ®Google Scholar
• Zatalia SR Sanusi H The role of antioxidants in the pathophysiology, complications, and management of diabetes mellitus Acta Med Indones 2013 45 141 147 23770795
   PubMedGoogle Scholar
• Clapés S Torres O Companioni M Peroxidación lipídica y otros indicadores de estrés oxidativo en pacientes diabéticos [Lipid peroxidation and other oxidative stress markers in diabetic patients] Rev Cubana Invest Biomed 2001 20 93 98 Spanish
   Google Scholar
• Margaritis M Channon KM Antoniades C Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering Antioxid Redox Signal 2014 20 1198 1215 24111702
   PubMed Web of Science ®Google Scholar
• Gazzerro P Proto MC Gangemi G Pharmacological actions of statins: a critical appraisal in the management of cancer Pharmacol Rev 2011 64 102 106 22106090
   PubMed Web of Science ®Google Scholar
• Fenster BE Tsao PS Rockson SG Endothelial dysfunction clinical strategies for treating oxidant stress Am Heart J 2003 146 218 226 12891188
   PubMed Web of Science ®Google Scholar
• Mennickent CS Bravo DM Calvo MC Avello LM Pleiotropic effects of statins Rev Med Chil 2008 136 775 782 Spanish 18769836
   PubMed Web of Science ®Google Scholar
• Giroux LM Davignon J Naruszewicz M Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages Biochim Biophys Acta 1993 1165 335 338 8380338
   PubMed Web of Science ®Google Scholar
• Parson HK Bundy MA Dublin CB Boyd AL Paulson JF Vinik AI Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes Diabetes Metab Syndr Obes 2010 3 19 26 21437072
   PubMedGoogle Scholar
• England JD Gronseth GS Franklin G Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation Neurology 2005 64 199 207 15668414
   PubMed Web of Science ®Google Scholar
• Tesfaye S Boulton A Dyck P Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity and treatments Diabetes Care 2010 33 2285 2293 20876709
   PubMed Web of Science ®Google Scholar
• Tierney EF Thurman DJ Beckles GL Cadwell BL Association of statin use with peripheral neuropathy in the US population 40 years of age or older J Diabetes 2013 5 207 215 23121724
   PubMed Web of Science ®Google Scholar
• West B Williams CM Jilbert E James AM Haines TP Statin use and peripheral sensory perception: a pilot study Somatosens Mot Res 2014 31 57 61 24219409
   PubMed Web of Science ®Google Scholar
• Sohn MW Meadows JL Oh EH Statin use and lower extremity amputation risk in nonelderly diabetic patients J Vasc Surg 2013 58 1578 1585 23932803
   PubMed Web of Science ®Google Scholar
• McIlduff CE Rutkove SB Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy Ther Clin Risk Manag 2011 7 377 385 21941444
   PubMed Web of Science ®Google Scholar
• Poh ZX Goh KP A current update on the use of alpha lipoic acid in the management of type 2 diabetes mellitus Endocr Metab Immune Disord Drug Targets 2009 9 392 398 19601918
   PubMedGoogle Scholar
• Golbidi S Badran M Laher I Diabetes and alpha lipoic acid Front Pharmacol 2011 2 69 72 22125537
   PubMed Web of Science ®Google Scholar
• Ziegler D Ametov A Barinov A Oral treatment with α-lipoic acid improves symptomatic diabetic polyneuropathy. SYDNEY 2 trial Diabetes Care 2006 29 2365 2370 17065669
   PubMed Web of Science ®Google Scholar
• Wassmann S Laufs U Baumer AT HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species Hypertension 2001 37 1450 1457 11408394
   PubMed Web of Science ®Google Scholar
• Li M Nishimura H Kusano KF Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy Circulation 2005 112 93 102 15983249
   PubMed Web of Science ®Google Scholar
• Fujii T Onimaru M Yonemitsu Y Kuwano H Sueishi K Statins restore ischemic limb blood flow in diabetic microangiopathy via eNOS/NO upregulation but not via PDGF-BB expression Am J Physiol Heart Circ Physiol 2008 294 H2785 H2791 18441206
   PubMed Web of Science ®Google Scholar
• Thomas PK Classification, differential diagnosis, and staging of diabetic peripheral neuropathy Diabetes 1997 46 54 57
   PubMed Web of Science ®Google Scholar
• Arca M Pigna G Treating statin-intolerant patients Diabetes Metab Syndr Obes 2011 4 155 166 21779147
   PubMedGoogle Scholar
• Settergren J Eiermann B Mannheimer B Adherence to drug label recommendations for avoiding drug interactions causing statin-induced myopathy – a nationwide register study PLoS One 2013 8 e69545 23940522
   PubMed Web of Science ®Google Scholar
• Shishehbor MH Brennam ML Aviles RJ Statins promote potent systemic antioxidants effects through specific inflammatory pathways Circulation 2003 108 426 431 12860913
   PubMed Web of Science ®Google Scholar
• Abe M Maruyama N Okada K Matsumoto S Matsumoto K Soma M Effects of lipid-lowering therapy with rosuvastatin on kidney function and oxidative stress in patients with diabetic nephropathy J Atheroscler Thromb 2011 18 1018 1028 21921413
   PubMed Web of Science ®Google Scholar